EXOMIND

BTL-995 · BTL Industries Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for EXOMIND, covering 2025-07-21 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway [NA]